Veradermics, Inc. (MANE)
142.30
+3.52
(+2.54%)
USD |
NYSE |
Nov 09, 10:37
Veradermics Price to Book Value : 7.302 for Nov. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 7.121 |
| November 05, 2026 | 6.599 |
| November 04, 2026 | 7.005 |
| November 03, 2026 | 6.856 |
| November 02, 2026 | 6.647 |
| October 30, 2026 | 7.168 |
| October 29, 2026 | 7.382 |
| October 28, 2026 | 7.380 |
| October 27, 2026 | 7.221 |
| October 26, 2026 | 7.05 |
| October 23, 2026 | 7.121 |
| October 22, 2026 | 7.106 |
| October 21, 2026 | 7.012 |
| October 20, 2026 | 6.522 |
| October 19, 2026 | 6.275 |
| October 16, 2026 | 5.584 |
| October 15, 2026 | 5.905 |
| October 14, 2026 | 5.823 |
| October 13, 2026 | 5.966 |
| October 12, 2026 | 6.281 |
| October 09, 2026 | 6.717 |
| October 08, 2026 | 6.498 |
| October 07, 2026 | 5.693 |
| October 06, 2026 | 5.591 |
| October 05, 2026 | 6.100 |
| Date | Value |
|---|---|
| October 02, 2026 | 5.991 |
| October 01, 2026 | 6.015 |
| September 30, 2026 | 6.221 |
| September 29, 2026 | 6.046 |
| September 28, 2026 | 5.901 |
| September 25, 2026 | 5.982 |
| September 24, 2026 | 5.938 |
| September 23, 2026 | 5.941 |
| September 22, 2026 | 6.062 |
| September 21, 2026 | 5.788 |
| September 18, 2026 | 5.478 |
| September 17, 2026 | 5.577 |
| September 16, 2026 | 5.256 |
| September 15, 2026 | 5.331 |
| September 14, 2026 | 5.219 |
| September 11, 2026 | 5.078 |
| September 10, 2026 | 5.036 |
| September 09, 2026 | 5.114 |
| September 08, 2026 | 5.328 |
| September 04, 2026 | 5.055 |
| September 03, 2026 | 5.016 |
| September 02, 2026 | 5.052 |
| September 01, 2026 | 5.004 |
| August 31, 2026 | 5.050 |
| August 28, 2026 | 5.025 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 32.69 |
| ANI Pharmaceuticals, Inc. | 2.453 |
| Corcept Therapeutics, Inc. | 9.643 |
| Veru, Inc. | 1.310 |
| Johnson & Johnson | 8.202 |
Price to Book Value Related Metrics
| PEG Ratio | -0.1549 |
| Price | 142.30 |
| Earnings Yield | -1.83% |
| Market Cap | 5.945B |
| PEGY Ratio | -0.1549 |